death from semaglutide Nurse's linked to weight-loss drug Mounjaro approved on NHS Off-Label Semaglutide Linked to Deaths,

Insulin lispro U-200 should not be mixed with any other insulin, nor should it be administered intravenously or used with insulin pumps

2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events A 2024 Meta-analysis of 13 multiple cardiovascular outcome trials has documented that GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)

Push the plunger slightly to expel the air

Schtz F et al

Retatrutide can generate as much as 28.7% average weight loss at 68 weeks, compared to semaglutides lower percentage over approximately the same time period